PATENT CLAIM ANALYSIS

Application Number: 15754782
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["514", "04400A"]

Abstract:
The present disclosure relates to modified antisense oligomers and related compositions and methods for increasing the expression of functional SMN protein and methods for treating spinal muscular atrophy and relates to inducing inclusion of exon 7 in SMN2 mRNA.

Claim (Index 11):
The compound of 7, wherein each R 1  is \u2014N(CH 3 ) 2 , R 2  is selected from H and acyl, and T is of the formula:

Metadata:
- Claim Count in Document: 11.0
- Percentile: 88.0
- Lexical Diversity: 1.25
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14360895', '14713857', '14714104', '11801885', '15727483']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7841333084886576
- 35 USC 102 Novelty (BERT): 0.5467922255572127
- Combined Prediction Score: 0.7603992001955131
- Mean Citation Score: 368.839766
- Max Citation Score: 393.62296
- Similarity Product: 248.42204239670752

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test